|
Status |
Public on Jan 23, 2015 |
Title |
DNA from PBMC P14, baseline |
Sample type |
genomic |
|
|
Source name |
PBMCs, before rhGH treatment
|
Organism |
Homo sapiens |
Characteristics |
cell type: peripheral blood mononuclear cells treatment: none patient: 14
|
Treatment protocol |
4 days of rhGH treatment during IGF-1 generation test.
|
Growth protocol |
None.
|
Extracted molecule |
genomic DNA |
Extraction protocol |
DNeasy Blood and Tissue Kit (Qiagen).
|
Label |
Cy5 and Cy3
|
Label protocol |
Standard Illumina Protocol.
|
|
|
Hybridization protocol |
Bisulfite-converted DNA was amplified, fragmented and hybridised to Illumina Infinium Human Methylation450 Beadchip using standard Illumina protocol.
|
Scan protocol |
Arrays were scanned using the Illumina iScan.
|
Description |
P14_baseline IGF-1 generation test
|
Data processing |
GenomeStudio software (version 2011.1, Methylation module version 1.9.0).
|
|
|
Submission date |
Apr 25, 2014 |
Last update date |
Jan 23, 2015 |
Contact name |
Susanne Bens |
E-mail(s) |
sbens@medgen.uni-kiel.de
|
Organization name |
Christian-Albrechts-University Kiel & University Hospital Schleswig-Holstein
|
Department |
Institute of Human Genetics
|
Street address |
Arnold-Heller-Str.3 (Haus 10)
|
City |
Kiel |
ZIP/Postal code |
D-24105 |
Country |
Germany |
|
|
Platform ID |
GPL13534 |
Series (2) |
GSE57107 |
In vivo investigations of the effect of short- and long-term recombinant growth hormone treatment on DNA-methylation in humans |
GSE57205 |
In vivo investigations of the effect of short- and long-term recombinant growth hormone treatment on DNA-methylation in humans |
|